03 February 2017 1 Min Read
Weak rand hurts HIV/AIDS medicines leading to ARV shortage
The government spends R14.2bn on antiretrovirals from local pharmaceutical groups, but the weak rand is causing problems as ingredients are imported
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In